New England Retina Associates
Quick facts
Marketed products
- Topical Prednisolone Acetate 1% · Ophthalmology
Prednisolone acetate is a topical corticosteroid that suppresses local inflammatory and immune responses in the eye by binding to glucocorticoid receptors.
Phase 3 pipeline
- Ranibizumab injection and TTT - ICG based · Ophthalmology
Ranibizumab is a monoclonal antibody fragment that blocks vascular endothelial growth factor (VEGF) to reduce abnormal blood vessel growth in the retina, combined with transpupillary thermotherapy (TTT) using indocyanine green (ICG) guidance for targeted thermal ablation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: